{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/058/SRR13648758/SRR13648758.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/061/SRR13648761/SRR13648761.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/059/SRR13648759/SRR13648759.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/062/SRR13648762/SRR13648762.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/057/SRR13648757/SRR13648757.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR136/060/SRR13648760/SRR13648760.fastq.gz"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Beth Israel Deaconess Medical Center"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA700438"],"tag":["xref:EuropePMC:PMC8051863"],"long_description":["Blockade of 6-Phosphogluconate dehydrogenase generates CD8+ effector T cellswith enhanced anti-tumor function"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"Blockade of 6-Phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function","dates":{"last_updated":"2023-05-19","first_public":"2022-03-05"},"accession":"PRJNA700438","cross_references":{}}